BSE Sensex gains some, NSE Nifty drops, as Ranbaxy Laboratories shares fall off cliff

Comments 0
Ranbaxy Laboratories Ltd provisionally slumped 30 percent to mark its lowest close in nearly one month. Reuters Ranbaxy Laboratories Ltd provisionally slumped 30 percent to mark its lowest close in nearly one month. Reuters
SummaryBSE Sensex wiped out over 350-point rise to end with a meagre 9.71-point rise

Food and Drug Administration, while faster-than-expected rise in August inflation also weighed. BSE Sensex on the other hand logged marginal gains.

*Stocks: Top Gainers/Top Losers

Ranbaxy Laboratories Ltd provisionally slumped 30 percent to mark its lowest close in nearly one month, while IT shares including Tata Consultancy Services (TCS) shares fell 3 percent as the Indian rupee rose over 1 percent to the US dollar.

The broader NSE Nifty index fell 0.07 percent while the benchmark BSE index ended 0.05 percent higher.

Top Stories:

US delays Rs 14,500 cr Cooper Tire, Onkar Kanwar's Apollo Tyres deal

Ranbaxy Laboratories shares fall 32 pct after another FDA ban, co pleads ignorance

Foreign funds (foreign institutional investors) sold $12.3 million in Indian equities, while they bought $118.4 million in debt on Sept. 13, stock market regulator data showed on Monday.

Single Page Format
Ads by Google
Reader´s Comments
| Post a Comment
Please Wait while comments are loading...